Transversus Abdominis Plane Blocks With and Without Dexamethasone

NCT05432934 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-12-07

No results posted yet for this study

Summary

Dexamethasone will be used as an adjunct to local anesthetics (bupivacaine) to prolong the duration of laparoscopically-placed transversus-abdominis plane blocks in elective colorectal resection.

Conditions

  • Colorectal Disorders
  • Regional Anesthesia Morbidity
  • Analgesia
  • Local Anesthetic Complication
  • Pain, Postoperative
  • Colorectal Cancer
  • Crohn Disease
  • Diverticular Diseases

Interventions

DRUG

Dexamethasone

Dexamethasone will be added to local anesthetic solution and injected at 4 site for for laparoscopically placed TAP blocks.

Sponsors & Collaborators

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • David N Ginther, MD · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2024-03-31
Completion
2024-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05432934 on ClinicalTrials.gov